Publications
Publications
P Thapak, Z Ying, F Gomez-Pinilla, (2025). Enduring Effects of Humanin on Mitochondrial Systems in TBI Pathology. Biomolecules 15 (12), 1705.
P Thapak, and F Gomez-Pinilla (2024). The Bioenergetics of Traumatic Brain Injury and its Long-Term Impact for Brain Plasticity and Function. Pharmacological Research 208, 107389.
F Gomez-Pinilla and P Thapak (2024). Exercise epigenetics is fueled by cell bioenergetics: Supporting role on brain plasticity and cognition. Free Radic Biol Med 220, 43-55.
P Thapak, G Smith, Z Ying, A Paydar, N Harris, F Gomez-Pinilla. (2023). The BDNF mimetic R-13 attenuates TBI pathogenesis using TrkB-related pathways and bioenergetics. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869(7), 166781.
P Thapak, Z Ying, V Palafox-Sanchez, G Zhang, X Yang, F Gomez-Pinilla, (2023) Humanin ameliorates TBI-related cognitive impairment by attenuating mitochondrial dysfunction and inflammation. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1870 (2), 166937.
G Smith, P Thapak, A Paydar, Z Ying, F Gomez-Pinilla, NG Harris, (2023) Altering the Trajectory of Perfusion-Diffusion Deficits Using A BDNF Mimetic Acutely After TBI is Associated with Improved Functional Connectivity. Progress in neurobiology (Dover, Del.) 10 (1).
B Vaidya, H Kaur, P Thapak, SS Sharma, JN Singh, (2022) Pharmacological modulation of TRPM2 channels via PARP pathway leads to neuroprotection in MPTP-induced Parkinson’s disease in Sprague Dawley rats. Molecular Neurobiology 59 (3), 1528-1542.
P Thapak, B Vaidya, HC Joshi, JN Singh, SS Sharma, (2020) Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders. Pharmacological Research 159, 105026.
P Thapak, P Khare, M Bishnoi, SS Sharma (2022) Neuroprotective effect of 2-aminoethoxydiphenyl borate (2-APB) in Amyloid β-induced memory dysfunction: a mechanistic study. Cellular and Molecular Neurobiology 42 (4), 1211-1223
P Thapak, M Bishnoi, SS Sharma, (2020) Pharmacological inhibition of transient receptor potential melastatin 2 (TRPM2) channels attenuates diabetes-induced cognitive deficits in rats: a mechanistic study. Current Neurovascular Research 17 (3), 249-258.
P Thapak, M Bishnoi, SS Sharma, (2020) Amelioration of diabetes-induced cognitive impairment by Transient Receptor Potential Vanilloid 2 (TRPV2) channel inhibitor: Behavioral and mechanistic study. Neurochemistry International 139, 104783
P Thapak, M Bishnoi, SS Sharma, (2022) Tranilast, a Transient Receptor Potential Vanilloid 2 Channel (TRPV2) inhibitor attenuates amyloid β-induced cognitive impairment: Possible mechanisms. NeuroMolecular Medicine 24(2), 183-194.